Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1996 3
1997 1
1998 3
1999 2
2000 3
2001 2
2002 5
2003 4
2004 10
2005 5
2006 6
2007 8
2008 6
2009 16
2010 12
2011 11
2012 6
2013 13
2014 10
2015 19
2016 15
2017 14
2018 11
2019 11
2020 9
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

179 results
Results by year
Filters applied: . Clear all
Page 1
UGT2B17 modifies drug response in chronic lymphocytic leukaemia.
Allain EP, Rouleau M, Vanura K, Tremblay S, Vaillancourt J, Bat V, Caron P, Villeneuve L, Labriet A, Turcotte V, Le T, Shehata M, Schnabl S, Demirtas D, Hubmann R, Joly-Beauparlant C, Droit A, Jäger U, Staber PB, Lévesque E, Guillemette C. Allain EP, et al. Among authors: guillemette c. Br J Cancer. 2020 Jul;123(2):240-251. doi: 10.1038/s41416-020-0887-6. Epub 2020 May 18. Br J Cancer. 2020. PMID: 32418995 Free PMC article.
UGT genomic diversity: beyond gene duplication.
Guillemette C, Lévesque E, Harvey M, Bellemare J, Menard V. Guillemette C, et al. Drug Metab Rev. 2010 Feb;42(1):24-44. doi: 10.3109/03602530903210682. Drug Metab Rev. 2010. PMID: 19857043 Free article. Review.
PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics.
Alvarellos M, Guillemette C, Altman RB, Klein TE. Alvarellos M, et al. Among authors: guillemette c. Pharmacogenet Genomics. 2018 May;28(5):127-137. doi: 10.1097/FPC.0000000000000331. Pharmacogenet Genomics. 2018. PMID: 29517518 Free PMC article. No abstract available.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.
Gammal RS, Court MH, Haidar CE, Iwuchukwu OF, Gaur AH, Alvarellos M, Guillemette C, Lennox JL, Whirl-Carrillo M, Brummel SS, Ratain MJ, Klein TE, Schackman BR, Caudle KE, Haas DW; Clinical Pharmacogenetics Implementation Consortium. Gammal RS, et al. Among authors: guillemette c. Clin Pharmacol Ther. 2016 Apr;99(4):363-9. doi: 10.1002/cpt.269. Epub 2015 Nov 9. Clin Pharmacol Ther. 2016. PMID: 26417955 Free PMC article. Review.
Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, Ritter JK. Wells PG, et al. Among authors: guillemette c. Drug Metab Dispos. 2004 Mar;32(3):281-90. doi: 10.1124/dmd.32.3.281. Drug Metab Dispos. 2004. PMID: 14977861 Review.
Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.
Lévesque E, Labriet A, Hovington H, Allain ÉP, Melo-Garcia L, Rouleau M, Brisson H, Turcotte V, Caron P, Villeneuve L, Leclercq M, Droit A, Audet-Walsh E, Simonyan D, Fradet Y, Lacombe L, Guillemette C. Lévesque E, et al. Among authors: guillemette c. Br J Cancer. 2020 Mar;122(7):1068-1076. doi: 10.1038/s41416-020-0749-2. Epub 2020 Feb 12. Br J Cancer. 2020. PMID: 32047296 Free PMC article.
179 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page